5-96879799-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022350.5(ERAP2):āc.114C>Gā(p.Phe38Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000719 in 1,614,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022350.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ERAP2 | NM_022350.5 | c.114C>G | p.Phe38Leu | missense_variant | 2/19 | ENST00000437043.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ERAP2 | ENST00000437043.8 | c.114C>G | p.Phe38Leu | missense_variant | 2/19 | 1 | NM_022350.5 | P1 | |
ENST00000501338.5 | n.1689-6421G>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000350 AC: 88AN: 251096Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135702
GnomAD4 exome AF: 0.000746 AC: 1091AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.000693 AC XY: 504AN XY: 727216
GnomAD4 genome AF: 0.000460 AC: 70AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000470 AC XY: 35AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.114C>G (p.F38L) alteration is located in exon 2 (coding exon 1) of the ERAP2 gene. This alteration results from a C to G substitution at nucleotide position 114, causing the phenylalanine (F) at amino acid position 38 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at